Chłoniak grudkowy: rozpoznawanie i leczenie

Decision-making to treat in the frontline is based on the algorithms described by the GELF (Group d'Etude des Lymphomes Folliculaires) or BNL (British National Lymphoma) group. The general approach should be immunochemotherapy based on CHOP or CVP regimens, with more recent evidence for the alternative bendamustine. Therapeutic options for relapsed/refractory FL include the same regimens traditionally used for the first-line therapy. Finally, hematopoietic stem cell transplantation (both autologous and allogeneic) remains a useful treatment strategy, although the optimal timing of such approaches requires further clarification.